| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-08 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-07 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.24 | 5e-06 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.2 | 3e-05 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |